Literature DB >> 28211687

Isolation and Structure Elucidation of Glucosylated Colchicinoids from the Seeds of Gloriosa superba by LC-DAD-SPE-NMR.

Yancho Zarev1, Kenn Foubert1, Iliana Ionkova2, Sandra Apers1, Luc Pieters1.   

Abstract

Four new colchicinoids were isolated from the seeds of Gloriosa superba together with the known compounds colchicoside (4) and 3-de-O-methylcolchicine-3-O-β-d-glucopyranosyl-(1→4)-3-O-β-d-glucopyranoside (6), by means of conventional column chromatography and LC-DAD-SPE-NMR. The new compounds were identified as N-deacetyl-N-formyl-3-de-O-methylcolchicine-3-O-β-d-glucopyranoside (1), 3-de-O-methylcolchicine-3-O-β-d-glucopyranosyl-(1→6)-3-O-β-d-glucopyranoside (2), N-deacetyl-N-formyl-3-de-O-methylcolchicine-3-O-β-d-glucopyranosyl-(1→6)-3-O-β-d-glucopyranoside (3), and 3-de-O-methylcolchicine-3-O-β-d-glucopyranosyl-(1→3)-3-O-β-d-glucopyranoside (5). The structure elucidation was performed by means of NMR (COSY, HSQC, and HMBC), HRESIMS/MS, and GCMS data analysis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28211687     DOI: 10.1021/acs.jnatprod.6b01024

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

Review 1.  Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.

Authors:  Emmanuelle Lautié; Olivier Russo; Pierre Ducrot; Jean A Boutin
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

2.  Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development.

Authors:  Bharat Goel; Biswajit Dey; Essha Chatterjee; Nancy Tripathi; Nivedita Bhardwaj; Sanjay Kumar; Santosh Kumar Guru; Shreyans K Jain
Journal:  ACS Omega       Date:  2022-08-12

3.  Anticancer Secondary Metabolites: From Ethnopharmacology and Identification in Native Complexes to Biotechnological Studies in Species of Genus Astragalus L. and Gloriosa L.

Authors:  Iliana Ionkova; Aleksandar Shkondrov; Yancho Zarev; Ekaterina Kozuharova; Ilina Krasteva
Journal:  Curr Issues Mol Biol       Date:  2022-08-26       Impact factor: 2.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.